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Recognition of DNA by the innate immune system is
central to antiviral and antibacterial defenses, as well
as an important contributor to autoimmune diseases
involving self DNA. AIM2 (absent in melanoma 2) and
IFI16 (interferon-inducible protein 16) have been
identified as DNA receptors that induce inflamma-
some formation and interferon production, respec-
tively. Here we present the crystal structures of
their HIN domains in complex with double-stranded
(ds) DNA. Non-sequence-specific DNA recognition
is accomplished through electrostatic attraction
between the positively charged HIN domain residues
and the dsDNA sugar-phosphate backbone. An
intramolecular complex of the AIM2 Pyrin and HIN
domains in an autoinhibited state is liberated by
DNA binding, which may facilitate the assembly of
inflammasomes along the DNA staircase. These find-
ings provide mechanistic insights into dsDNA as the
activation trigger and oligomerization platform for
the assembly of large innate signaling complexes
such as the inflammasomes.
INTRODUCTION
The innate immune system responds to the presence of cyto-
solic DNA molecules through the secretion of interferons and
proinflammatory cytokines (Hornung and Latz, 2010) and the
activation of antigen-presenting cells to induce potent adaptive
immune responses (Kis-Toth et al., 2011). Multiple cytosolic
innate DNA receptors/sensors have been reported, including
DAI (DNA-dependent activator of IRFs) (Takaoka et al., 2007),
LRRFIP1 (leucine-rich repeat and flightless I interacting protein1) (Yang et al., 2010), and DDX41 (DEAD box polypeptide 41)
(Zhang et al., 2011). In addition, the RNA sensor RIG-I (retinoic
acid inducible gene I) indirectly detects DNA transcribed by
RNA polymerase III (Ablasser et al., 2009).
Recently, a family of DNA-recognizing innate receptors was
identified among the HIN-200 proteins (hematopoietic inter-
feron-inducible nuclear proteins with a 200 amino acid repeat)
(Goubau et al., 2010; Ludlow et al., 2005), such as AIM2 (Bu¨rck-
stu¨mmer et al., 2009; Fernandes-Alnemri et al., 2009; Hornung
et al., 2009) and IFI16 (Kerur et al., 2011; Unterholzner et al.,
2010). A third DNA-binding protein, p202, was reported to be
an inhibitor of the AIM2 signaling (Roberts et al., 2009). Both
AIM2 and IFI16 contain C-terminal DNA-binding HIN domain(s)
and an N-terminal Pyrin (PYD) domain that belongs to the
death domain superfamily of signaling modules, and thus were
renamed as the PYHIN family of receptors (Hornung et al.,
2009; Schattgen and Fitzgerald, 2011) or the AIM2-like receptors
(Unterholzner et al., 2010). AIM2 is predominantly a cytosolic
protein that responds to dsDNA from both host and pathogens
to form large signaling platforms known as the inflammasomes
(Davis et al., 2011; Schroder and Tschopp, 2010), which
also contain the adaptor protein ASC (apoptosis-associated
speck-like protein containing a caspase recruitment domain)
and effector enzyme procaspase-1. These macromolecular
complexes control the activation of procaspase-1 and subse-
quent maturation and secretion of IL-1b and IL-18. Innate recep-
tors such as NLRP1, NLRP3, NLRP6, NLRP7, NLRC4, NAIP,
AIM2, and IFI16 are known to form inflammasomes that respond
to ligands or stimuli from various microbial or host sources. A
major challenge in the field has been the lack of concrete
evidence of direct receptor:ligand association for many of the
inflammasomes, and therefore the true identities of the respec-
tive ligands are still unknown. In contrast, cellular and biochem-
ical evidence has confirmed that AIM2 and IFI16 (see below)
directly interact with dsDNA (Fernandes-Alnemri et al., 2009;
Hornung et al., 2009; Unterholzner et al., 2010).Immunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc. 561
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Figure 1. The HIN:DNA Interactions Are Not Sequence Specific and
Are Sensitive to Ionic Strength
(A) Fluorescence polarization (FP) assays of the FAM-labeled dsDNAs of
various sequences and GC contents upon binding to the AIM2 HIN domain.
The apparent Kd values (Kda) are shown for each dsDNA.
(B and C) FP assays of the FAM-labeled dsDNA ODN787/788 upon binding to
the AIM2 HIN domain (B) and the IFI16 HINb domain (C) in the presence of
various concentrations of sodium chloride.
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HIN Domains Bind the DNA Sugar-Phosphate BackboneIFI16 was originally identified as an antiproliferative and DNA
damage response protein in the nucleus (Choubey et al.,
2008). Recently, IFI16 and its mouse homolog p204 were shown
to be cytosolic dsDNA receptors that induce interferon produc-
tion (Unterholzner et al., 2010). IFI16 was also reported to form
inflammasomes sensing DNA viruses replicating in the nucleus
(Kerur et al., 2011). The cytosolic signaling pathway for interferon
induction downstream of IFI16 appears to require the ER-resi-
dent protein STING (stimulator of interferon genes) (Ishikawa
et al., 2009; Unterholzner et al., 2010), which itself was shown
to be a nucleotide sensor that induces type I IFN production
(Burdette et al., 2011). Both AIM2 and IFI16 respond to dsDNA
from various sources irrespective of their sequences or GC
contents (Fernandes-Alnemri et al., 2009; Hornung et al., 2009;
Unterholzner et al., 2010), consistent with the principal require-
ment of the innate immune responses to diverse microbial
threats as well as cellular stress. As such, these innate receptors
play crucial roles in host defense against intracellular pathogens
such as Francisella tularensis, vaccinia virus, and herpes simplex
virus type 1 (Fernandes-Alnemri et al., 2010; Jones et al., 2010;
Rathinam et al., 2010; Unterholzner et al., 2010), as well as in
autoimmune disease such as systemic lupus erythematosus
(SLE) in which DNA is a major autoimmune target (Veeranki
and Choubey, 2010).
Despite the elucidation of innate RNA recognition by the
structures of the TLR3:dsRNA complex (Liu et al., 2008) and
RIG-I:RNA complex (Jiang et al., 2011; Kowalinski et al., 2011;
Lu et al., 2010; Luo et al., 2011; Wang et al., 2010), the mecha-
nism for innate recognition of dsDNA, particularly the common
B-form dsDNA as the primary stimulator of the cytosolic sensors
(Ishii et al., 2006), remains elusive. The crystal structures of the
HINa and HINb domains from IFI16 (Liao et al., 2011) demon-
strated that each HIN domain contains two tandem b barrels of
80 residues previously characterized as the OB (oligonucleo-
tide/oligosaccharide binding) fold (Albrecht et al., 2005), but the
mode of HIN:DNA interaction remains unknown. Furthermore,
the mechanisms of receptor oligomerization for the AIM2 and
IFI16 inflammasomes are unclear. Neither AIM2 nor IFI16
contains an oligomerization domain, even though such domains
were essential for other inflammasome receptors as evidenced
by themajority of their dysfunctional mutations at these domains
(Aksentijevich et al., 2007; Schroder and Tschopp, 2010).
To understand the mechanisms of dsDNA recognition,
receptor activation, and oligomerization, we determined the
crystal structures of the HIN domains from both AIM2 and
IFI16 in complex with the B-form dsDNA. Our findings establish
electrostatic attraction as the basis for non-sequence-specific
DNA recognition, identify DNA as the ligand that releases the
signaling domain PYD from its intramolecular complex with the
HIN domain, and define themultivalent ligand dsDNA as the olig-
omerization platform for the inflammasome formation.
RESULTS
Overview of the HIN:DNA Complex Structures
Previous reports demonstrated that DNA of various sequences
or GC contents from host, microbial, and synthetic sources are
equivalent in their ability to stimulate AIM2 and IFI16 (Bu¨rckstu¨m-
mer et al., 2009; Fernandes-Alnemri et al., 2009; Hornung et al.,562 Immunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc.2009; Roberts et al., 2009; Unterholzner et al., 2010). In agree-
ment, here we showed quantitatively by a fluorescence polariza-
tion (FP) assay that different dsDNA bind the AIM2 HIN domain
with comparable apparent affinities (Figure 1A and Table S1
available online). The HIN:DNA binding was sensitive to salt
concentrations (Figures 1B and 1C), suggesting essential contri-
butions from ionic interactions. We chose to use the dsDNA
derived from the vaccinia virus genomic repeat sequences
(Baroudy and Moss, 1982) for further crystallographic studies
(Table S1) and determined the crystal structures of the AIM2
HIN:DNA and IFI16 HINb:DNA complexes at 2.5–2.6 A˚ resolu-
tions (Figures 2A, 2B, S1A, and S1B; Table S2).
In spite of different crystal lattice packing, common modes of
DNA binding by the HIN domains are evident upon inspection of
the structures. The HIN:DNA complexes feature positively
charged HIN domains embracing the dsDNA sugar-phosphate
backbone in a concave surface of the protein (Figures 2C, 2D,
and S1C–S1F). Bonding between the HIN domain basic residues
with the nonesterified phosphate oxygens dominates the
HIN:DNA interface, in agreement with previous observations
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Figure 2. Overview of the HIN:DNA Complexes
(A) The structure of the AIM2 HIN:DNA complex (crystal form I) is represented
as lime- and cyan-colored ribbons for each HIN domain and electrostatic
charge surface for the dsDNA on a scale of 10 kT/e (red) to 10 kT/e (blue).
Locations of the N termini of the HIN domains are marked.
(B) Structure of the IFI16 HINb:DNA complex is shown as lime, cyan, light pink,
and wheat ribbons for each HINb domain and orange ribbon for the dsDNA.
Locations of the N termini of the HIN domains are marked.
(C) Structure of the AIM2 HIN:DNA complex is rotated 90 along the horizontal
axis from the view in (A) and represented as electrostatic charge surface for the
HIN domains and orange ribbon for the dsDNA.
(D) Structure of the IFI16 HINb:DNA complex is represented as electrostatic
charge surface for the HIN domains and orange ribbon for the dsDNA. The
view is rotated 90 horizontally from that in (B).
See also Figure S1.
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HIN Domains Bind the DNA Sugar-Phosphate Backbonethat nonbridging phosphoryl oxygens are critical for aligning
DNA-binding proteins (Harrison, 1991). In addition, the N termini
of the HIN domains are all located distal to the DNA-binding
interface (Figures 2A and 2B), potentially facilitating interaction
of the N-terminal PYD domain with downstream adaptor ASC
at the periphery of the receptor assembly. Importantly, both
AIM2 and IFI16 HIN domains bind both strands of the dsDNA,
across both major and minor grooves (Figures 3A, 3B, and
S2A–S2C), in keeping with the requirement for dsDNA instead
of ssDNA for innate signaling by AIM2 and IFI16 (Bu¨rckstu¨mmer
et al., 2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009;
Unterholzner et al., 2010).
Both OB Folds and the Linker between Them Engage
the dsDNA Backbone
The DNA-binding surface of the AIM2 and IFI16 HIN domains
consists of both OB folds (hereafter referred to as OB1 and
OB2) and the linker between them (Figures 3 and S2; Table
S3). The DNA interface from the OB1 of AIM2 is centered at resi-
dues K162 and K163 between b1 and b10 strands and at K198and K204 near the a1 helix. The OB1-OB2 linker contains amphi-
pathic a2-a3 helices that contribute hydrogen bonds and van der
Waals (vDW) contacts from R244, K251 or G247, and T249 for
different AIM2 HIN domains. The OB2 of AIM2 HIN forms salt
bridges and vDW contacts with DNA through residues R311 at
the b4 strand and residues K335 and I337 at the b5 strand.
R311 faces the minor groove of the dsDNA and forms bidentate
hydrogen bonds with a DNA backbone phosphate (Figures 3A,
S2A, and S2B), unlike those from sequence-specific DNA-
binding proteins that extend into the minor groove to contact
the bases (Rohs et al., 2009). AIM2 HIN domains from two
different crystal forms also employ distinctive DNA-binding
residues bordering the above core DNA interface (Table S3),
suggesting flexible interface with DNA. Overall, there is 1,000–
1,200 A˚2 of solvent-accessible surface area buried between
each AIM2 HIN domain and their DNA partners.
In comparison, the IFI16 HINb-DNA interfaces bury 700–
800 A˚2 of solvent-accessible surface area, consistent with the
lower DNA-binding affinity. Most of the IFI16 HINb DNA-binding
residues are located at the OB1-OB2 linker and OB2 that form
side chain and main chain hydrogen bonds as well as vDW
contacts with the DNA backbone phosphates (Figures 3B and
S2C; Table S3). These include residues K663 and R667 at the
linker a2 helix and residues K732, K734, and R764 near the b4
and b5 strands. Even at the modest resolutions, many water
molecules are visible along the DNA double strands, with some
mediating protein-DNA interactions (Figures S2A–S2C).
Sequence alignment of the HIN domains illustrates that the
DNA-binding residues are largely conserved between the AIM2
HIN and IFI16 HINb domains (Figure 3C), in particular those at
the a1-b4 loops from OB1, the linker a2 helices, and the b4-b5
strands from OB2. In accord with its higher affinity for DNA, the
AIM2 HIN domain also contributes additional DNA-binding resi-
dues at its b1 strands from both OB1 and OB2, which are
conserved in mouse AIM2. The structures also explain the
different DNA-binding affinities of the IFI16 HINa and HINb
domains (Unterholzner et al., 2010). Residues K663 and R667
at the IFI16 HINb linker a2 helix are shifted in their positions
compared with those at the IFI16 HINa domain and therefore
would locate the HINa residues away from the DNA interface.
Additionally, the DNA-binding residues K734 and R764 from
IFI16 HINb are not conserved in the HINa domains from either
IFI16 or mouse p204, consistent with the lower DNA-binding
affinities for the HINa domains (Unterholzner et al., 2010).
The HIN:DNA structures also demonstrates versatile modes of
DNA binding: superposition of the HIN domains shows that their
bound dsDNA can tilt and slide relative to the HIN domains
(Figures 3C and S2D–S2F), partly because of the flexible lysine
and arginine residues that dominate the HIN:DNA interface.
Comparison of the IFI16 HINb structures in the presence and
absence of dsDNA illustrates no major conformational changes
(Figure S2G), suggesting that the DNA-binding surface of the
HIN domains is preformed.
Mutations of Key Residues at the HIN:DNA Interface
Compromises DNA Binding
To probe the functional relevance of the observed HIN:DNA
interactions, mutagenesis studies were carried out for the
DNA-binding residues individually and in groups based on theirImmunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc. 563
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HIN Domains Bind the DNA Sugar-Phosphate Backbonelocations at the OB1, linker, and OB2 (Figures 4 and S3; Table
S4). We first measured the apparent DNA-binding affinities of
the wild-type and mutant AIM2 HIN domains by using the FP
assay. Our data showed that several AIM2 HIN domain single-
residue mutants had lower affinities for DNA (higher apparent
Kd values), such as K204A at OB1 (m3), K251A at the OB1-
OB2 linker (m5), and K309A at OB2 (m6), whereas point mutation
at other sites such as K198A at OB1 (m2) or R311A at OB2 (m7)
did not significantly affect the HIN:DNA interaction (Figures 4A
and S3A). In comparison, grouped mutations showed more
prominent effects, with the mutant m12 harboring the most
mutations retaining the weakest DNA-binding activity. To inves-
tigate whether positively charged residues outside of the
HIN:DNA interface are important for DNA binding, we mutated
three basic residues (K276A, K277A, and K278A) located at
the opposite site of the AIM2 HIN domain DNA-binding surface.
This mutant (m0) possesses the same DNA-binding affinity as
the wild-type, suggesting that basic residues extraneous to the
HIN:DNA interface are not essential for the interaction (Table
S4). A mutation of F165A was previously reported to impair the
association of AIM2 with DNA (Bu¨rckstu¨mmer et al., 2009).
This residue is located at the OB1-OB2 interface to anchor the
OB1 b1-b10 strands containing the DNA-binding residues
K160, K162, andK163, aswell as the adjacent K198 (Figure S3B).
Consistent with the published result, the F165A mutant m13
possesses a diminished DNA-binding affinity comparable to
that of the m10 or m11 mutant, in which the majority of the
mutated DNA-binding residues reside in OB1 (Table S4).
To further investigate the significance of theHIN:DNA interface
in the context of the full-length AIM2 protein, we introduced
some of the same mutations above in the intact AIM2 and
measured the DNA-binding affinities. Similar to our data for the
isolated HIN domains, mutations at the non-DNA binding surface
(m0) or a single mutation at the linker region (m5) did not signif-
icantly affect DNA binding by the full-length AIM2 protein (Fig-
ure S3C; Table S4). By contrast, grouped mutants m10 (OB1)
and m12 (OB1, linker, and OB2) showed much diminished affin-
ities for DNA, confirming that the DNA-binding residues are
important for ligand association by the intact receptor.
In comparison to the AIM2 HIN domain, the IFI16 HINb has
a much lower DNA-binding affinity (Figures 4B and S3D; Table
S4), perhaps reflecting the presence of the HINa-b tandem in
the full-length IFI16 receptor, and consistent with previous
observations that the HINa-b tandem bound DNA much tighter
than either HINa or HINb alone (Unterholzner et al., 2010). Muta-
tion of the OB1-OB2 linker (m1) and OB1 (m2) only marginally
reduced the HINb:DNA interaction. In contrast, DNA bindingFigure 3. The HIN Domains Bind Both Strands of the dsDNA
(A) Detailed HIN:DNA interactions for the AIM2 HIN:DNA complex. The hydrogen b
domain (lime) are labeled and the two DNA strands are colored yellow and silver
a magenta dotted line and the major and minor grooves of the dsDNA are marke
(B) Detailed HIN:DNA interactions are shown for the IFI16 HINb:DNA complex si
(C) Sequence alignment of the HIN domains. Sequences of selected dsDNA-bindin
human IFI16 (Q16666), mouse p204 (NP_032355, a homolog of human IFI16), m
superfamily protein RPA (NP_002936) were aligned by ClustalW (Thompson et al.
underlined in green and marked with ‘‘I’’ and ‘‘II’’ for OB1 and OB2, respectively. C
boxes.
See also Figure S2.was severely compromised by mutations at OB2 (m3), suggest-
ing that it is essential for DNA association. Importantly, an irrele-
vant mutant (m0) harboring mutations of five basic residues
retained comparable DNA-binding affinity as the wild-type
protein, again suggesting that non-DNA contacting basic resi-
dues are not essential for binding (Table S4). Because all of
the mutations are localized at the surface of the HIN domains,
they are unlikely to disrupt the proper domain folding. This
is illustrated by the structure of an IFI16 HINb mutant containing
K663A and R667A mutations (Table S2, IFI16 crystal form III),
which is essentially the same as the wild-type protein
(Figure S2G).
Intact DNA-Binding Surface Is Essential for Association
with and Innate Response to DNA
To examine the HIN:DNA interaction in cells, confocal micros-
copy was employed to study the colocalization and clustering
of the AIM2 HIN domains with DNA in HEK293T cells or AIM2-
deficient mouse macrophages (Figures 4C and 4D). We show
that the wild-type but not mutant AIM2 HIN domain colocalized
with DNA in HEK293T cells, and quantitative analysis in macro-
phages demonstrated diminished DNA colocalization for the
mutant AIM2 HIN domain compared with the wild-type (Fig-
ure 4E). Our attempts to analyze DNA colocalization with the
full-length AIM2 protein were hampered by severe protein aggre-
gation and cellular pyroptosis, perhaps because of the presence
of the PYD domain that induced excessive protein oligomeriza-
tion and activation of the full-length receptor by the transfected
plasmid DNA. Nevertheless, our data with the AIM2 HIN domain
confirm the important contribution of the DNA-binding residues
to the HIN:DNA association and are consistent with our kinetic
measurements of the HIN:DNA and full-length AIM2:DNA inter-
actions (see above).
To further study the impact of the above mutations on the
function of the full-length receptors in mammalian cells, we per-
formed assays for inflammasome formation and interferon
reporter with the full-length AIM2 and IFI16, respectively (Fig-
ure 5). Mutation of the DNA-binding residues for the AIM2 m10
and m12 mutants (Table S4) significantly diminished the matura-
tion of IL-1b by the AIM2 inflammasome (Figure 5A, compare the
IL-1b bands from lanes 4, 8, and 12). Similarly, when the IFI16/
STING pathway was reconstituted in HEK293T cells, disruption
of the IFI16 HINb DNA-binding residues impaired its ability to
induce the IFN-b promoter in response to the transfected
plasmid DNA (Figure 5B). The residual IFN-b induction by the
IFI16 mutant may be partially due to the presence of the wild-
type HINa domain from the IFI16 receptor that is known toonds are indicated as gray dotted lines. Secondary structures for the AIM2 HIN
, respectively. The approximate boundaries of the OB1-OB2 are marked with
d in gray.
milar to (A), except the IFI16 HINb domain is colored cyan.
g HIN domains from human AIM2 (NP_004824), mouse AIM2 (NP_001013801),
ouse p202 (NP_032353, an inhibitor of AIM2), as well as a ssDNA-binding OB
, 1994) with minor adjustments. The a helices are in red, and the b strands were
onserved residues are shaded in yellow, and DNA binding residues are in black
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Figure 4. Mutagenesis Studies of the
HIN:DNA Interactions
(A) Wild-type and mutant AIM2 HIN domains were
assayed for DNA binding and their apparent Kd
values are plotted in a bar graph. Locations of the
mutations for each mutant are marked below the
graph. The ‘‘m0’’ mutants contain mutations of
basic residues outside the DNA-binding surface.
More details on the mutation sites are listed in
Table S4. Panels of the binding curves for each
mutant are presented in Figure S3A.
(B) Wild-type and mutant IFI16 HINb domains
were assayed for DNA binding and their apparent
Kd values are plotted in a bar graph. Locations of
the mutations for each mutant are marked below
the graph. The ‘‘m0’’ mutants contain mutations of
basic residues outside the DNA-binding surface.
More details on the mutation sites are listed in
Table S4. Panels of the binding curves for each
mutant are presented in Figure S3D.
(C) Colocalization of DNA with wild-type or mutant
(m12) AIM2 HIN domains containing a hemagglu-
tinin (HA) tag in HEK293T cells. Cells were stained
24 hr after transfection for AIM2 (HA antibody with
Alexa 647, red) and DNA (DAPI, blue). Regions of
colocalization aremarkedwith white arrows. Scale
bar represents 5 mm.
(D) Colocalization of FITC-labeled dsDNA (red)
with stably expressed wild-type or mutant (m12)
AIM2 HIN domains tagged with mCerulean (green)
in AIM2-deficient macrophages. Regions of co-
localization are marked with white arrows.
(E) The ratio of the number of dsDNA specks that
colocalized with the wild-type or mutant AIM2 HIN
domains to the total number of dsDNA specks
from (D) are shown for two full 1200 3 1200 pixel
mosaic images, respectively.
Data are presented as mean ± standard deviation.
See also Figure S3.
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HIN Domains Bind the DNA Sugar-Phosphate Backbonebind DNA (Unterholzner et al., 2010), as well as basal activation
of the IFN-b promoter by the overexpressed STING. The reduc-
tion in IL-1b secretion or IFN-b induction was not due to differen-
tial expression of the wild-type and mutant receptors, as
shown by the fact that they were expressed at comparable
levels for both AIM2 and IFI16 in transfected HEK293T cells,
with no observable endogeneous expression (Figures 5A,
bottom, and 5C).
DNA Displaces PYD Domain from Its Intramolecular
Complex with the HIN Domain
The HIN:DNA complex structures also suggested potential
mechanisms of receptor activation. We note that the size of
the AIM2PYDdomain (10 A˚ radius),modeledwith the ASCPYD
structure (de Alba, 2009), is very similar to that of a B-DNA
cylinder and may be able to bind at the concave basic surface
of the AIM2 HIN domain. We therefore tested whether the566 Immunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc.AIM2 PYD and HIN domains form a
protein complex, and if so, whether this
interaction is affected by DNA binding.
Transfection of the full-length AIM2
protein or its PYD domain caused severeprotein aggregation and pyroptosis, as noted above, and has so
far prevented us from analyzing the HIN:PYD domain interaction
in a cellular context. As an alternative, we employed a pull-down
assay with a maltose-binding protein (MBP) expression tag
linked to the AIM2 PYD domain. We show that the wild-type
AIM2 PYD and HIN domains form a protein complex, which
was disrupted by either the presence of dsDNA or mutation of
acidic residues in PYD (Figure 6A). Conversely, the AIM2 PYD
domain suppressed the HIN:DNA interaction (Figure 6B), even
though it has no DNA-binding capacity (Figure S4A). In agree-
ment, the full-length AIM2 receptor exhibited a decreased
DNA-binding affinity in vitro compared with the isolated AIM2
HIN domain (Figure S4B). We therefore envision a model in
which the PYD and HIN domains of AIM2 form an intramolecular
complex in an autoinhibited ‘‘resting’’ state, with the PYD-
binding and DNA-binding surface overlapping at the HIN
domain. DNA binding by the HIN domain activates the receptor
020
10
30
40
IF
N
 
 
lu
ci
fe
ra
se
 (fo
ld 
ind
uc
tio
n) 
EV IFI16
HA-IFI1680 kDa
IFI16
m5WT
EV IFI16
WT
IFI16
m5
EV IFI16
WT
IFI16
m5
EV STING
0
5
10
15
20
25
EV IFI16
WT
IFI16
m4
EV IFI16
WT
IFI16
m4
EV STING
EV
IFI16-WT IFI16-m4
HA-IFI1680 kDa
IF
N
 
 
lu
ci
fe
ra
se
 (fo
ld 
ind
uc
tio
n) 
A
B
C
  HA-AIM2 FL            WT         m12          m10 
ASC: 20 ng
Procasp-1: 5 ng
pro-IL-1
pro-IL-1
 IL-1
anti-HA
 1   2   3   4   5   6   7   8   9  10  11 12
ASC: 0 ng
Procasp-1: 5 ng
anti-AIM2
Figure 5. Innate Immune Responses by the Full-Length AIM2 and
IFI16 Receptors
(A) Reconstitution of the human AIM2 inflammasome via the wild-type or
mutant (m12 and m10) full-length HA-AIM2 and ASC, procaspase-1 and
luciferase-FLAG-tagged pro-IL-1b. Maturation of the IL-1b is indicated with
a black arrow. The expression levels of the wild-type or mutant full-length HA-
AIM2 are indicated at the bottom panels as probed by HA or AIM2 antibodies.
(B) Interferon-b promoter reporter assay for the wild-type full-length IFI16 or
IFI16 containing the HINb mutant m4 or m5 in HEK293T cells. EV indicates
empty expression vector.
(C) The expression levels of the wild-type or mutant full-length IFI16 proteins in
(B) are detected by immunoblotting 48 hr after transfection.
Data are presented as mean ± standard deviation.
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Figure 6. PYD Domain Inhibits the HIN:DNA Interaction
(A) Pull-down assay of the MBP, MBP-PYD wild-type, or mutant (containing
mutations of E7A, L11A, D15A, D19A, and E20A) with the AIM2 HIN domain.
The wild-type MBP-PYD (lane 4), but not mutant MBP-PYD (lane 8) or MBP
(lane 2), was able to pull down the AIM2 HIN domain, which was significantly
reduced by the addition of a 19-mer dsDNA ODN 736/737 (lane 6). I, input; E,
elution.
(B) The AIM2 PYD domain inhibits the HIN:DNA interaction. Increasing
concentrations of the wild-type or mutant AIM2 PYD domain were incubated
with an AIM2 HIN:DNA mixture, and the fluorescence polarization was
measured and analyzed with program Prism. The IC50 for the wild-type AIM2
PYD domain is 11 mM.
See also Figure S4.
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HIN Domains Bind the DNA Sugar-Phosphate Backbonethrough displacing the PYD domain from this intramolecular
complex, which facilitates the PYD domain downstream
signaling to the adaptor ASC (Figure S4C).
DNA Serves as an Oligomerization Platform for the AIM2
Inflammasome
The dsDNA molecules in the HIN:DNA crystals form pseudo-
continuous double helices through head-to-tail stacking, with
the HIN domains decorated along the DNA staircases. An
example from the AIM2 crystal form II is illustrated in Figures
S5A and S5B. Each HIN domain spans a spacing of 7–8 bp on
each side of the dsDNA. In the IFI16 HINb crystal form I,
a 16 bp dsDNA accommodates four HINb domains. It is possible
that two of the HINb domains (i.e., C and D molecules with less
interactions with DNA) (Table S3) may mimic the HINa domains
of IFI16, such that the four HINb domains may represent two
HINa-b tandems from two IFI16 molecules. Previous studies
demonstrated that 70 bp dsDNAs were required for optimalinterferon induction by IFI16 (Unterholzner et al., 2010). Based
on the assumption of theHINa-b tandem in the IFI16 HINb crystal
lattice, 70 bp may allow up to 9 IFI16 molecules with 18 HINa-b
domains to oligomerize as a signaling complex. Similarly, we
found that 80 bp of dsDNA transfected into cells is required
for optimal IL-1b induction (Figure 7), presumably through the
activation of AIM2. A dsDNAof this lengthmay be able to accom-
modate maximal 20 AIM2 HIN domains, although variable oligo-
merization states for the full-length AIM2 receptor are possible
because of its larger size and the nonspecific nature of DNA
binding. One hypothetical model of such a multimolecular
complex is presented in Figures S5C and S5D, with the crystallo-
graphic asymmetric unit of the AIM2 crystal form II as a template
to dock an AIM2 PYD domain model and the full-length ASC
structure (2KN6) (de Alba, 2009). Although the validity of the
AIM2 inflammasome model awaits future structural and func-
tional characterization, we note that oligomerization of the AIM2
receptors is unlikely to materialize in the absence of electrostatic
charge neutralization through the HIN domain:DNA interaction.
We therefore propose that instead of relying on a specializedImmunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc. 567
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Figure 7. Secretion of IL-1b Induced by DNA of Various Lengths
Human PBMCs were primed with LPS and transfected with the indicated
dsDNA or with MSU and ATP as controls. The culture supernatants were as-
sayed for IL-1b secretion 6 hr after transfection/stimulation.
Data are presented as mean ± standard deviation. See also Figure S5.
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HIN Domains Bind the DNA Sugar-Phosphate Backboneoligomerization domain as in other inflammasomes, AIM2 may
employ the multivalent ligand dsDNA as a platform to assemble
large signaling complexes such as the inflammasomes.
DISCUSSION
The structures reported here provide examples of non-
sequence-specific dsDNA recognition by innate immune recep-
tors through electrostatic attraction. This appears to be one of
the general principles of nucleic acid sensing by the innate
immune system, as indicated by the fact that electrostatic attrac-
tion also plays important roles in RNA recognition by TLR3 (Liu
et al., 2008) and RIG-I (Jiang et al., 2011; Luo et al., 2011; Kowa-
linski et al., 2011). The nonspecific nature of sensing universal
genomic materials allows the innate immune system to respond
to the presence of threat from either infectious agents or host
tissue damages. This type of interaction is indeed very common
among DNA-binding proteins, as shown by the fact that
‘‘nonspecific’’ binding to DNA backbone also plays an important
role in sequence-specific recognition by transcription factors
and restriction enzymes (Luscombe et al., 2001), for example
in the ‘‘facilitated diffusion’’ model (von Hippel and Berg,
1989). The nonspecific DNA interface is highly flexible, which is
reminiscent of the tilting and sliding of the dsDNA relative to
the HIN domains in our structures. It is conceivable that electro-
static attraction may have evolved into an integral component of
the innate nucleic acid recognition because of its nonspecific
and versatile nature.
Many signaling receptors reside in autoinhibited states in the
absence of their ligands, and activation of the receptors is often
accomplished by allosteric conformational changes (Pufall and
Graves, 2002). For example, the apoptotic protease activating
factor-1 (Apaf-1) contains a C-terminal WD-40 repeat domain
that represses its ability to activate procaspase-9 in the absence
of ligand (cytochrome C) binding, and ligand engagement by
WD-40 releases this inhibition to facilitate the formation of a large
macromolecular complex apoptosome (Hu et al., 1998; Sriniva-
sula et al., 1998). More recently, an auto-repression model was
proposed for the dsRNA receptor RIG-I, in which the RNA-568 Immunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc.binding helicase domain represses the CARD domains in the
resting state, and dsRNA binding results in a structural change
that facilitates downstream signaling by the CARD domains
(Jiang et al., 2011; Kowalinski et al., 2011; Luo et al., 2011). For
the DNA receptor AIM2, the apparently weak interaction
between the HIN and PYD domains is probably significantly
enhanced in the full-length receptor because of the high effective
local concentrations from their covalent linkage and can be dis-
rupted only by high-affinity multivalent ligand such as dsDNA.
The presence of cis-acting repressor domains in these receptors
is an effective regulatory mechanism to prevent spurious activa-
tion of the signaling pathways: the autoinhibited state of the
AIM2 receptor creates an elevated threshold for activation
that prevents excessive immune response to trace amounts of
nucleic acids or to other negatively charged cellular compo-
nents. The current work elucidated intramolecular interactions
between the isolated HIN and PYD domains, and future experi-
ments will further examine the autoinhibition model of the AIM2
receptor by using physiologically relevant cellular assays and
animal models. These should further illustrate the importance
of the exquisite control of innate receptor activation, as evi-
denced by diseases associated with inappropriate stimulation
of the inflammasomes (Aksentijevich and Kastner, 2011;
Schroder and Tschopp, 2010).
Regulation of the innate receptor oligomerization and inflam-
masome formationbears important physiological consequences.
Mutations in the oligomerization domains of NLRP3, NLRP12,
and NOD2 are associated with autoinflammatory disorders
CAPS (cryopyrin-associated periodic syndromes) (Aksentijevich
et al., 2007), FCAS2 (familial cold autoinflammatory syndrome
2) (Je´ru et al., 2008), and Blau syndrome (Miceli-Richard et al.,
2001), respectively. Such mutations are predicted to disrupt the
inactive conformations of the receptors in the monomeric states,
effectively lowering the threshold of inflammasome formation or
receptor activation (Aksentijevich et al., 2007; Aksentijevich and
Kastner, 2011). In comparison, AIM2 and IFI16 do not possess
known oligomerization domains, which may be surrogated by
the multivalent ligand dsDNA. Mutations in the receptors that
diminish DNA binding may result in reduced oligomerization
and signaling and compromised immune response to microbial
infections, whereas those that enhance DNA binding or destabi-
lize the autoinhibited state may be linked to autoimmune disor-
ders such as lupus and psoriasis. In this regard, the recent finding
that the antimicrobial peptide LL-37 suppresses the AIM2 inflam-
masome activation in a psoriasis model suggests that this family
of charged peptides may be exploited as anti-inflammatory
agents (Dombrowski et al., 2011). In conclusion, our structural
studies not only reveal the molecular basis of non-sequence-
specific dsDNA recognition and allow us to formulate a mecha-
nism of the receptor autoinhibition and oligomerization, but also
provide a framework for the design of therapeutic agents that
modulate immune defense against infections or alleviate symp-
toms of autoimmune and autoinflammatory disorders.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The human AIM2 HIN (residues 144–343) and IFI16 HINb (residues 571–766)
domains were cloned into a pET30a vector with a TEV cleavable N-terminal
Immunity
HIN Domains Bind the DNA Sugar-Phosphate Backboneprotein G b1 domain (GB1) tag or anMBP tag. Transformed BL21 (DE3) Codon
Plus RIPL cells (Stratagene, Santa Clara, CA) were grown at 37C and then
induced with 0.2 mM IPTG at 18C for 4 hr. Cells were lysed by sonication in
buffer A (20 mM Tris-HCl [pH 8.0], 100 mM NaCl) plus 5 mM imidazole, DNase
(Biomatik, Wilmington, DE), and protease inhibitors (Roche Applied Science,
Indianapolis, IN). Soluble protein was purified from cell lysate by Hisprep
IMAC column (GE Healthcare Bio-Sciences, Piscataway, NJ). Nonspecific
nucleic acid contaminants were removed by 0.1% polyethyleneimine (PEI)
precipitation followed by 3M ammonium sulfate precipitation. The protein
pellet was dissolved in buffer A before TEV protease cleavage. Further purifi-
cation was carried out with a second IMAC column and size exclusion chroma-
tography. The AIM2 PYD domain (residues 1–107) was purified by the same
protocol as outlined above, without the PEI and ammonium sulfate precipita-
tion steps.
Crystallization
DNA oligos were synthesized by IDT (Coralville, IA) and dissolved in buffer B
(20 mM HEPES-Na [pH 7.4], 100 mM KCl, and 5 mM DTT). The oligos were
annealed by heating to 95C and slowly cooling to room temperature.
Annealed dsDNAwere added to protein solutions in buffer B and concentrated
by centrifugal concentrators (Millipore, Billerica, MA) to 10–20 mg/ml before
setting up hanging drop vapor diffusion method for crystallization. The AIM2
HIN:DNA complexes were crystallized with a well solution containing 8%
PEG 1000, 100 mM KCl, 10 mM MgCl2, and 100 mM MES-Na [pH 6.5]. The
IFI16 HINb:dsDNA complex was crystallized with a reservoir solution contain-
ing 20% PEG 3350, 100 mM potassium formate, and 100 mM HEPES-Na
(pH 7.0). 20% ethylene glycol (v/v) was added to the reservoir solutions as
the cryoprotectant to freeze the AIM2 HIN or IFI16 HINb crystals in liquid
nitrogen for X-ray diffraction data collection.
X-Ray Diffraction, Structure Determination, and Refinement
X-ray diffraction data were collected at GM/CA-CAT at the Advanced Photon
Source, Argonne National Laboratory (ANL). Data were processed with
HKL2000 program suite (Otwinowski and Minor, 1997) and XDS (Kabsch,
2010). The IFI16 HINb-DNA and AIM2 HIN:DNA structures were determined
by molecular replacement (MR) with Phaser (McCoy et al., 2007). A deposited
IFI16 HINb structure (3B6Y) (Liao et al., 2011) and ideal dsDNA from Coot
(Emsley and Cowtan, 2004) and make_na server (Lakshiminarayanan and
Sasisekharan, 1970) were used as the initial search models. Structure building
and refinement were carried out with Coot (Emsley and Cowtan, 2004) and
Phenix (Adams et al., 2010). DNA base pair hydrogen bonding restraints
from the PDBto3D restraints server (Laurberg et al., 2008) and TLS parameters
generated by the TLSMD server (Painter and Merritt, 2006) or Phenix (Adams
et al., 2010) were applied throughout the refinement. Twinned refinement
protocols were applied for the AIM2 crystal forms I and II and IFI16 crystal
form I as suggested by program Xtriage from Phenix (Adams et al., 2010).
The crystal structures were validated by the Molprobity server (Chen et al.,
2010) and RCSB ADIT validation server (Yang et al., 2004). Solvent-accessible
surface area was calculated with program Areaimol from the CCP4 suite (Lee
and Richards, 1971; Potterton et al., 2003). Electrostatics surfaces were calcu-
lated with program Delphi (Honig and Nicholls, 1995) and displayed with
program Pymol (Delano Scientific LLC, San Carlos, CA).
Fluorescence Polarization Assay
50-fluorescein (FAM)-labeled (IDT, Coralville, IA) 20-mer DNA oligo ODN 787
(Table S1) was dissolved in buffer B and annealed with its reverse complement
ODN 788. 3 nM dsDNA were used for the AIM2 HIN and IFI16 HINb FP assays.
Purified IFI16 HINb or AIM2 HIN samples were mixed with the FAM-labeled
dsDNA and diluted into assay buffers containing 20 mM HEPES-Na (pH 7.4)
and 100 mM NaCl for the AIM2 HIN domains and 50 mM NaCl for the IFI16
HINb domains. The mixtures were then aliquoted in triplets into black 96-
well plates and fluorescence polarization was measured with a Paradigm
spectrometer (Molecular Devices, Sunnyvale, CA). For the inhibition assay,
increasing concentrations of the AIM2 PYD domain or the KS-30 peptide
was added to a mixture of 0.1 mM MBP-AIM2 HIN domain and 3 nM
FAM-labeled 20-mer dsDNA and the fluorescence polarization wasmeasured.
Data were analyzed and plotted with program GraphPad Prism version 5.0
(GraphPad Software, San Diego, CA).Confocal Microscopy
Colocalization of the AIM2 HIN domains with DNA was studied with HEK293T
cells and immortalized AIM2-deficient macrophages. Wild-type or mutant HA-
AIM2-HIN constructs were transfected into HEK293T cells and the cells were
stained with Alexa 647-labeled anti-HA antibody (red) and DAPI (4,6-diami-
dino-2-phenylindole, blue). AIM2-deficient immortalized macrophages (Rathi-
nam et al., 2010; Hornung et al., 2008) were transfected with mCerulean-fused
AIM2 HIN domains (green) and FITC-labeled dsDNA (red). The ratio of the
number of the dsDNA specks that colocalized with the AIM2 HIN domain to
the total number of dsDNA specks was determined after setting a threshold
on the fluorescence intensity of the AIM2HINmCerulean based on the average
intensity of the cells.
Reconstitution of the AIM2 Inflammasomes
Reconstitution of the AIM2 inflammasome was carried out as previously
described (Hornung et al., 2009), with HA-tagged AIM2 full-length expression
constructs, Guassia-luciferase-FLAG-tagged pro-IL-1b (54 kDa), procas-
pase-1, and ASC expression constructs transfected into HEK293T cells. Cell
lysates were probed with mouse anti-IL-1b monoclonal antibody (Clone
3ZD, National Cancer Institute, NIH). The expression levels for the AIM2
proteins were probed with HA antibody (Roche Applied Science) and AIM2
antibody (R. Johnstone, University of Melbourne, Australia).
Luciferase Reporter Gene Assay
Luciferase reporter gene assays were performed with HEK293T cells seeded
in 96-well pates and transfected with firefly reporter construct under the
control of the IFN-b promoter, GL3-Renilla control plasmid, STING expression
vector, and IFI16 expression vector. Cell lysates were assayed for the firefly
luciferase activity and normalized to the renilla luciferase activity. The expres-
sion levels of thewild-type ormutant full-length IFI16 weremeasured by immu-
noblotting with HA antibody (Sigma, St. Louis, MO) 48 hr after transfection.
MBP Pull-Down Assay
Purified AIM2 HIN domain and wild-type or mutant MBP-AIM2-PYD domain
(containing mutations of E7A, L11A, D15A, D19A, and E20A) were mixed in
buffer A with amylose beads (New England Biolabs, Inc., Ipswich MA) and
rocked at room temperature for 2 hr. The beads were pelleted and washed
twice with buffer A and the bound protein was eluted with the 25 mMmaltose.
To test the effects of the dsDNA ligand on the HIN:PYD domain interaction,
a 19-mer dsDNA (annealed from ODN 736 and ODN 737) was added to the
HIN:PYD mixture upon binding to the amylose beads. Purified MBP protein
was used as a control for nonspecific interactions between the HIN domain
and either the MBP tag or the amylose beads.
Stimulation of IL-1b Secretion with dsDNA
Stimulation of IL-1b secretion was carried out with human peripheral blood
mononuclear cells (PBMCs) and dsDNA of various length. Human PBMCs
were obtained from healthy, volunteer blood donors under signed informed
consent with approval from the Institutional Review Board of the University
of Massachusetts Medical School. Cells were primed with 200 pg/ml LPS
for 3 hr and transfected with indicated nucleic acids. ATP (5 mM) or monoso-
dium urate (MSU, 250 mg/ml) was used as positive controls. 6 hr after stimula-
tion supernatants were collected and assayed for IL-1b by ELISA. Data from
one representative experiment out of two independent experiments (mean
values + SEM) are depicted.
Modeling of the AIM2 Inflammasome
Construction of a hypothetical AIM2 inflammasome model was accomplished
through sequential docking of the AIM2 PYD model and then the full-length
ASC structure (de Alba, 2009) onto the HIN:DNA structures from the AIM2
crystal form II via program HEX (Ritchie et al., 2008). This DNA:AIM2:ASC
model with a dsDNA footprint of 16 bp was then propagated along a dsDNA
staircase five times. The spacing among these five copies were chosen so
they are well separated without steric clashes, but was otherwise arbitrary.
The total footprint of the AIM2:ASC complexes at the dsDNA is 100 bp.
The resulting model was subjected to energy minimization with the relax
mode of the Rosetta program (v3.2) (Kuhlman et al., 2003).Immunity 36, 561–571, April 20, 2012 ª2012 Elsevier Inc. 569
Immunity
HIN Domains Bind the DNA Sugar-Phosphate BackboneACCESSION NUMBERS
The PDB accession codes for the AIM2 HIN:DNA and IFI16 HINb:DNA struc-
tures listed in Table S2 are 3RN2, 3RN5, 3RNU, 3RLO, and 3RLN.
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